Home › Funds › W.G. Shaheen & Associates DBA Whitney & Co › RMD
W.G. Shaheen & Associates DBA Whitney & Co position in RMD
RESMED INC · Health Care
W.G. Shaheen & Associates DBA Whitney & Co reported holding 48,411 shares of RMD (RESMED INC) in its Q3 2026 13F filing — a position valued at US$10.7M, representing 0.76% of its reported portfolio and ranking #41 among its reported holdings. W.G. Shaheen & Associates DBA Whitney & Co has disclosed RMD holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How W.G. Shaheen & Associates DBA Whitney & Co's RMD position evolved
W.G. Shaheen & Associates DBA Whitney & Co first disclosed a stake in RMD in Q4 2023 at 28,869 shares (US$5.0M). The position peaked in Q3 2024 at 57,455 shares, worth US$14.0M. Across 12 filings, W.G. Shaheen & Associates DBA Whitney & Co increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 48,411 shares valued at US$10.7M — a reduction of -602 shares quarter over quarter.. Notable position changes include a 82% increase in Q2 2024 (shares rose 28% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 28.87K | $4.97M | New |
| Q1 2024 | 30.97K | $6.13M | Add |
| Q2 2024 | 56.34K | $10.79M | Add |
| Q3 2024 | 57.45K | $14.03M | Add |
| Q4 2024 | 50.99K | $11.66M | Reduce |
| Q1 2025 | 52.49K | $11.75M | Add |
| Q2 2025 | 53.53K | $13.81M | Add |
| Q3 2025 | 49.53K | $13.56M | Reduce |
| Q4 2025 | 48.98K | $11.80M | Reduce |
| Q1 2026 | 48.85K | $10.97M | Hold |
| Q2 2026 | 49.01K | $9.55M | Hold |
| Q3 2026 | 48.41K | $10.70M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RMD and 13F data
RMD (RESMED INC) is a Health Care company. 31 other funds we track also report a position in RMD — the largest reported positions include Ilex Capital Partners (UK) LLP (US$163.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RMD
- Ilex Capital Partners (UK) LLP 737.47K sh · $163.06M · Q3 2026
More on W.G. Shaheen & Associates DBA Whitney & Co
FAQ
How long has W.G. Shaheen & Associates DBA Whitney & Co held RMD?
W.G. Shaheen & Associates DBA Whitney & Co has disclosed RMD holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is W.G. Shaheen & Associates DBA Whitney & Co's current position in RMD?
As of Q3 2026, W.G. Shaheen & Associates DBA Whitney & Co holds 48.41K shares of RMD (RESMED INC), valued at $10.70M, representing 0.76% of its reported portfolio and ranking #41.
Has W.G. Shaheen & Associates DBA Whitney & Co been buying or selling RMD?
In the latest 13F filing (Q3 2026), W.G. Shaheen & Associates DBA Whitney & Co reduced its position in RMD. The position peaked in Q3 2024 at 57.45K shares.
Which other funds hold RMD?
Other major institutional holders of RMD include Ilex Capital Partners (UK) LLP, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.